Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Sarilumab Chemical Structure
BCP31891 Sarilumab 1189541-98-7
Sarilumab is a human monoclonal antibody against the interleukin-6 receptor.
Evolocumab Chemical Structure
BCP25203 Evolocumab 1256937-27-5
Evolocumab is a monoclonal antibody designed to bind to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface. In the absence of PCSK9, there are more LDL receptors on the surface of liver cells to remove LDL-C from the blood.
Ixekizumab Chemical Structure
BCP29780 Ixekizumab 1143503-69-8
Ixekizumab is a humanized immunoglobulin G subclass 4 (IgG4) monoclonal antibody (mAb) against interleukin-17A (IL-17A) and prevents it from interacting with the IL-17A receptor.
Gemtuzumab Chemical Structure
BCP30538 Gemtuzumab 220578-59-6
Gemtuzumab is a monoclonal antibody to CD33 linked to a cytotoxic agent from the class of calicheamicins.
Canakinumab Chemical Structure
BCP30537 Canakinumab 914613-48-2
Canakinumab is a human monoclonal antibody targeted at interleukin-1 beta.
Brentuximab Vedotin Chemical Structure
BCP30536 Brentuximab Vedotin 914088-09-8
Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).
Belimumab Chemical Structure
BCP30531 Belimumab 356547-88-1
Belimumab is a human monoclonal antibody that inhibits B-cell activating factor (BAFF),also known as B-lymphocyte stimulator (BLyS).
Trastuzumab emtansine Chemical Structure
BCP30527 Trastuzumab emtansine 1018448-65-1
Trastuzumab emtansine is an antibody-drug conjugate (ADC), a combination between a monoclonal antibody and a small-molecule drug. Each molecule of trastuzumab emtansine consists of a single trastuzumab molecule with several molecules of DM1, a cytotoxic maytansinoid, attached.
Abciximab Chemical Structure
BCP30526 Abciximab 143653-53-6
Abciximab is a glycoprotein IIb/IIIa receptor antagonist and a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery.
Golimumab Chemical Structure
BCP30499 Golimumab 476181-74-5
Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.
123下一页末页共 57 条记录 1 / 6 页